Zacks: Analysts Anticipate Innospec Inc. (IOSP) Will Announce Earnings of $1.35 Per Share

Analysts predict that Innospec Inc. (NASDAQ:IOSP) will report $1.35 earnings per share (EPS) for the current quarter, according to Zacks. Zero analysts have made estimates for Innospec’s earnings. Innospec reported earnings of $1.47 per share in the same quarter last year, which suggests a negative year over year growth rate of 8.2%. The firm is expected to issue its next quarterly earnings report on Tuesday, February 12th.

According to Zacks, analysts expect that Innospec will report full-year earnings of $4.55 per share for the current year. For the next fiscal year, analysts expect that the firm will report earnings of $4.75 per share. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for Innospec.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings data on Tuesday, November 6th. The specialty chemicals company reported $1.20 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.06 by $0.14. The company had revenue of $363.10 million for the quarter, compared to analysts’ expectations of $362.50 million. Innospec had a return on equity of 14.02% and a net margin of 4.17%. Innospec’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $1.00 EPS.

A number of brokerages have commented on IOSP. Zacks Investment Research raised Innospec from a “sell” rating to a “hold” rating in a research note on Wednesday, September 26th. ValuEngine raised Innospec from a “hold” rating to a “buy” rating in a research note on Wednesday, November 7th. KeyCorp reduced their target price on Innospec from $86.00 to $83.00 and set a “buy” rating on the stock in a research note on Friday, November 16th. Finally, BidaskClub raised Innospec from a “hold” rating to a “buy” rating in a research note on Tuesday, November 20th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Innospec presently has an average rating of “Buy” and a consensus price target of $84.50.

Innospec stock traded down $0.78 during trading hours on Friday, reaching $66.08. The company had a trading volume of 75,550 shares, compared to its average volume of 70,301. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.27 and a quick ratio of 1.37. The stock has a market capitalization of $1.63 billion, a P/E ratio of 14.18 and a beta of 1.11. Innospec has a 12-month low of $62.13 and a 12-month high of $83.20.

The company also recently declared a semiannual dividend, which was paid on Thursday, November 29th. Investors of record on Monday, November 19th were given a dividend of $0.45 per share. The ex-dividend date was Friday, November 16th. This represents a dividend yield of 1.18%. Innospec’s dividend payout ratio is presently 19.31%.

A number of institutional investors have recently added to or reduced their stakes in the business. Itau Unibanco Holding S.A. purchased a new stake in Innospec during the second quarter valued at $116,000. First Hawaiian Bank purchased a new stake in Innospec during the third quarter valued at $147,000. UBS Group AG increased its position in Innospec by 69.3% during the first quarter. UBS Group AG now owns 2,771 shares of the specialty chemicals company’s stock valued at $190,000 after acquiring an additional 1,134 shares during the last quarter. Burney Co. purchased a new stake in Innospec during the second quarter valued at $207,000. Finally, GSA Capital Partners LLP purchased a new stake in Innospec during the third quarter valued at $213,000. 93.69% of the stock is currently owned by institutional investors and hedge funds.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.

See Also: Asset Allocation

Get a free copy of the Zacks research report on Innospec (IOSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply